Help
RSS
API
Feed
Maltego
Contact
Domain > www.ocrevus.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-09-16
52.9.196.166
(
ClassC
)
2024-12-12
104.18.31.114
(
ClassC
)
2025-01-28
104.18.30.114
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Thu, 24 Oct 2024 04:17:26 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Thu, 24 Oct 2024 05:17:26 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Thu, 24 Oct 2024 04:17:26 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivevary: Accept-EncodingCF-Cache-Status: DYNAMICSet-Cookie: __cf_bme !DOCTYPE HTML>html langen-US> head> meta charsetUTF-8/> title>OCREVUS® (ocrelizumab) | Multiple Sclerosis (MS) Treatment/title> meta namedescription contentLearn about OCREVUS® (ocrelizumab), a prescription medicine used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive multiple sclerosis, available in 3 different administration options: a 4-hour infusion, a 2-hour infusion, or a new 10-minute subcutaneous injection. See full safety for more information./> meta nametemplate contentflexible-page/> meta nameviewport contentwidthdevice-width, initial-scale1/> link relcanonical hrefhttps://www.ocrevus.com//> meta propertyog:site_name contentocrevus/> meta propertyog:type contentwebsite/> meta propertyog:locale contenten_US/> meta propertyog:title contentOCREVUS® (ocrelizumab) | Multiple Sclerosis (MS) Treatment/> meta propertyog:description contentLearn about OCREVUS® (ocrelizumab), a prescription medicine used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive multiple sclerosis, available in 3 different administration options: a 4-hour infusion, a 2-hour infusion, or a new 10-minute subcutaneous injection. See full safety for more information./> meta propertyog:url contenthttps://www.ocrevus.com//> meta propertyog:image contenthttps://www.ocrevus.com/content/dam/gene/ocrevus/english/logo/OCREVUS_Logo_Dosing_desktop.genecoreimg.1200.png/> meta propertyog:image:type contentimage/png/> meta propertyog:image:width content656/> meta propertyog:image:height content200/> meta propertyog:image:alt contentOCREVUS® (ocrelizumab) 300mg/10ml Injection for IV/> meta nametwitter:card contentsummary_large_image/> meta namepub_date content2024-09-13T17:30:38-0700/> link relicon typeimage/x-icon href/content/dam/gene/ocrevus/english/images/favicon.ico/> link relshortcut icon typeimage/x-icon href/content/dam/gene/ocrevus/english/images/favicon.ico/> link hre
Subdomains
Date
Domain
IP
smetrics.ocrevus.com
2024-12-12
63.140.37.126
www.ocrevus.com
2024-12-12
104.18.31.114
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]